The United States
George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialized oncology CRO division
George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialized oncology CRO division
George Clinical, the leading Asia-Pacific CRO, continues to expand its presence in the USA beyond oncology but also in renal, vascular and neurology therapeutic areas.
Headquartered in Sydney, Australia, George Clinical has offices in China, India, Hong Kong, South Korea, Taiwan, Malaysia, New Zealand, United Kingdom, and multiple offices in the USA.
Over the years, George Clinical has grown rapidly across the Asia-Pacific region and is continuing to develop its global operations. The combination of a strong commercial proficiency and clinical research and scientific excellence positions George Clinical as a high quality, global CRO with substantial clinical and scientific assets.
George Clinical’s operations now expand further in the USA, with nearly 100 people and leaders specializing in oncology, renal, vascular and neurology trials. We offer full-service capabilities for the clinical trials we manage for our important clients. We are here to support our USA customers with their clinical trial and scientific leadership needs and to lead trials across our core operational facilities in the Asia-Pacific and European regions.
| Population | 322 million |
|---|---|
| Official Language | English 79.2%, Spanish 12.9%, other Indo-European 3.8%, Asian and Pacific island 3.3%, other 0.9% |
| Hospital Records Language | English |
| In-country services | Project Management Business Development Scientific Leadership Oncology specialists Clinical Operations Clinical Compliance Regulatory Services Medical and Safety management Data Management Statistics |
